Convergent solid-phase synthesis of hirudin

Journal of Peptide Science

Volumn 12, Issue 2, 2006, Pages 116-123

  Goulas, Spyros ^a   Gatos, Dimitrios ^a   Barlos, Kleomenis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

2 chlorotrityl resin; Convergent synthesis; Hirudin; Oxidative folding; Protected peptide fragments; Solid phase fragment condensation; Solid phase peptide synthesis

Indexed keywords

CYSTEINE; HIRUDIN; IODINE; RESIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; LINKAGE ANALYSIS; OXIDATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS; SOLID PHASE SYNTHESIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIRUDINS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS;

STAPHYLOCOCCUS AUREUS;

EID: 32544449787     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.691     Document Type: Article

References (14)

1. Markwardt F. Untersuchungen uber hirudin. Naturwissenschaften 1955; 42: 537-538.
2. Dodt J, Muller H-P, Seemuller U, Chang JY. The complete amino acid sequence of hirudin, a thrombin-specific inhibitor. FEBS Lett. 1984; 165: 180-184.
3. Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 1986; 25: 4622-4628.
4. Walenga JM, Pifarre R, Hoppensteadt DA, Fareed J. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations. Semin. Thromb. Hemost. 1989; 15: 316-333.
5. Markwardt F. The development of hirudin as an antithrombotic drug. Thromb. Res. 1994: 74: 1-23.
6. Sohn JH, Kang HA, Rao KJ, Kim CH, Choi ES, Chung BH, Rhee SK. Current status of the anticoagulant hirudin: its biotechnological production and clinical practice. Appl. Microbiol. Biotechnol. 2001; 57: 606-613.
7. Chung BH, Kim WY, Rao KJ, Kim CH, Rhee SK. Downstream processing of recombinant hirudin produced in Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 1999; 9: 179-183.
8. Greinacher A. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy. Expert Rev. Cardiovasc. Ther. 2004; 2: 339-357.
9. Kang MC, Bray B, Lichty M, Mader C. Methods and Compositions for Peptide Synthesis, U.S.Patent 6,281,331, 2001.
10. Barlos K, Gatos D. Convergent peptide synthesis. In Fmoc Solid Phase Peptide Synthesis, A Practical Approach, Chan WC, White PD (eds). Oxford University Press: New York, 2000; 215-228.
11. Barlos K, Gatos D. 9-Fluorenylmethyloxy-carbonyl/tbutyl-based convergent protein synthesis. Biopolymers 1999; 51: 266-278.
12. Barlos K, Gatos D, Hatzi O, Koch N, Koutsogianni S. Synthesis of the very acid-sensitive Fmoc-Cys(Mmt)-OH and its application in solid-phase peptide synthesis. Int. J. Peptide Protein Res. 1996; 47: 148-153.
13. Chatrenet B, Chang J-Y. The folding of hirudin adopts a mechanism of trial and error. J. Biol. Chem. 1992; 267: 3038-3043.
14. Houmard J, Drapeau GR. Staphylococcal protease: A proteolytic enzyme specific for glutamoyl bonds. Proc. Natl. Acad. Sci. U.S.A. 1972; 69: 3506-3509.